Zantac
Sort by
3 items
-
Business - The New York Times
Zantac’s Developer Settles Lawsuits Claiming Cancer Link
GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.18 minutes ago -
Business - Financial Times
GSK reaches $2.2bn Zantac settlement in US
Agreement over heartburn medicine should help to resolve concerns hanging over UK drugmaker5 hours ago